$0.01 EPS Expected for Sky Solar Holdings Ltd (ADR) (SKYS); Ashford Capital Management Has Increased Ligand Pharmaceuticals (LGND) Position By $1.37 Million

August 23, 2017 - By Adrian Mccoy

Ashford Capital Management Inc increased Ligand Pharmaceuticals (LGND) stake by 12.72% reported in 2016Q4 SEC filing. Ashford Capital Management Inc acquired 13,589 shares as Ligand Pharmaceuticals (LGND)’s stock rose 7.66%. The Ashford Capital Management Inc holds 120,409 shares with $12.24M value, up from 106,820 last quarter. Ligand Pharmaceuticals now has $2.69 billion valuation. The stock increased 1.12% or $1.42 during the last trading session, reaching $127.97. About shares traded. Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has declined 2.87% since August 23, 2016 and is downtrending. It has underperformed by 19.57% the S&P500.

Analysts expect Sky Solar Holdings Ltd (ADR) (NASDAQ:SKYS) to report $0.01 EPS on September, 14.They anticipate $0.04 EPS change or 133.33% from last quarter’s $-0.03 EPS. SKYS’s profit would be $525,929 giving it 35.00 P/E if the $0.01 EPS is correct. The stock increased 1.01% or $0.01 on August 22, reaching $1.4. About shares traded. Sky Solar Holdings Ltd (ADR) (NASDAQ:SKYS) has declined 33.79% since August 23, 2016 and is downtrending. It has underperformed by 50.49% the S&P500.

Since February 27, 2017, it had 0 buys, and 7 selling transactions for $11.11 million activity. 37,247 shares were sold by Aryeh Jason, worth $4.13 million on Thursday, May 11. HIGGINS JOHN L sold $1.38M worth of stock. FOEHR MATTHEW W also sold $711,214 worth of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) on Thursday, March 2.

Ashford Capital Management Inc decreased Manhattan Associates Inc (NASDAQ:MANH) stake by 15,900 shares to 54,000 valued at $2.86 million in 2016Q4. It also reduced Ebix Inc. (NASDAQ:EBIX) stake by 17,654 shares and now owns 481,976 shares. Argan Inc. (NYSE:AGX) was reduced too.

Among 5 analysts covering Ligand Pharmaceuticals (NASDAQ:LGND), 4 have Buy rating, 0 Sell and 1 Hold. Therefore 80% are positive. Ligand Pharmaceuticals has $160 highest and $103 lowest target. $139’s average target is 8.62% above currents $127.97 stock price. Ligand Pharmaceuticals had 15 analyst reports since September 3, 2015 according to SRatingsIntel. Roth Capital maintained the shares of LGND in report on Monday, September 21 with “Buy” rating. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has “Overweight” rating given on Wednesday, April 13 by Stephens. The rating was maintained by Roth Capital on Wednesday, September 30 with “Buy”. The rating was maintained by H.C. Wainwright with “Buy” on Wednesday, October 5. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) has “Buy” rating given on Friday, December 18 by Roth Capital. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) earned “Buy” rating by Roth Capital on Friday, March 11. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) earned “Hold” rating by Deutsche Bank on Monday, July 17. The stock of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) earned “Buy” rating by TH Capital on Wednesday, September 30. The rating was maintained by TH Capital on Thursday, November 19 with “Buy”. Deutsche Bank maintained the shares of LGND in report on Tuesday, August 8 with “Hold” rating.

Investors sentiment increased to 1.2 in Q4 2016. Its up 0.12, from 1.08 in 2016Q3. It is positive, as 23 investors sold LGND shares while 85 reduced holdings. 39 funds opened positions while 91 raised stakes. 22.77 million shares or 1.00% less from 23.00 million shares in 2016Q3 were reported. Amer Century Incorporated holds 14,758 shares or 0% of its portfolio. Sector Pension Board stated it has 0.01% in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Moreover, Voya Investment Lc has 0.04% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Willingdon Wealth invested 0.64% in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Pictet Asset Management Ltd invested in 35,200 shares. Kalmar Invs De has invested 1.28% of its portfolio in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Blackrock Japan owns 0% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) for 185 shares. 154,483 are owned by Geode Cap Management Llc. Pnc Fincl Serv Gru Incorporated accumulated 13,808 shares or 0% of the stock. Moreover, Proshare Limited Liability Com has 0.02% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Falcon Point Limited Liability Company holds 2.24% of its portfolio in Ligand Pharmaceuticals Inc. (NASDAQ:LGND) for 164,246 shares. Invesco Ltd has 0.01% invested in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Massachusetts-based Fmr Limited Liability Company has invested 0.01% in Ligand Pharmaceuticals Inc. (NASDAQ:LGND). Employees Retirement Of Texas owns 15,000 shares for 0.02% of their portfolio. Cim Inv Mangement Incorporated stated it has 0.2% of its portfolio in Ligand Pharmaceuticals Inc. (NASDAQ:LGND).